Share Email Print
cover

Proceedings Paper

Anticancer activity of the new photosensitizers: dose and cell type dependence
Author(s): Grigor V. Gyulkhandanyan; Sona S. Ghambaryan; Gayane V. Amelyan; Robert K. Ghazaryan; Samvel G. Haroutiunian; Aram G. Gyulkhandanyan; Gennadi H. Gasparyan
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The necessity of researches of antitumor efficiency of new photosensitizers (PS) is explained by the opportunity of their application in photodynamic therapy of tumors. PS, selectively accumulated in cancer cells and activated by the light, generate the active oxygen species that cause apoptosis. Earlier, it was shown that PS chlorin e6 (0.3-0.5 μg/ml) induces rat embryo fibroblast-like cell apoptosis. In present work antitumor activity of the new photosensitizers, water-soluble cationic porphyrins and their metal complexes, is investigated. The dose-dependent destruction of cancer cells was shown on PC-12 (pheochromocytoma, rat adrenal gland) and Jurkat (human lymphoma) cell lines. Meso-tetra-[4-N-(2 `- oxyethyl) pyridyl] porphyrin (TOEPyP) and chlorin e6 possessed the same toxicity at LD50 dose on PC-12 cell line, whereas phototoxicity of TOEPyP was 3 times less compared to chlorin e6(LD50=0.2 and 0.075 μg/ml accordingly). The results have shown weak photosensitizing effect of Zn-and Ag-derivatives of TOEPyP on PC-12 cell line. TOEPyP and Zn-TOEPyP (0.1 - 50 μg/ml) were non-toxic for Jurkat cell line, whereas Ag-TOEPyP was toxic at 10 μg/ml (LD90). TOEPyP and chlorin e6 have shown phototoxic effect in the same dose range (LD50=0.5 and 0.3 μg/ml accordingly). The investigation of toxic and phototoxic effects of the new porphyrins revealed significantly different sensitivity of various cell lines to PSs.

Paper Details

Date Published: 8 April 2005
PDF: 6 pages
Proc. SPIE 5689, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XIV, (8 April 2005); doi: 10.1117/12.590050
Show Author Affiliations
Grigor V. Gyulkhandanyan, Institute of Biotechnology (Armenia)
Pharmagene Co. Ltd. (Armenia)
Sona S. Ghambaryan, Institute of Biotechnology (Armenia)
Gayane V. Amelyan, Institute of Biotechnology (Armenia)
Robert K. Ghazaryan, Yerevan State Medical Univ. (Armenia)
Samvel G. Haroutiunian, Yerevan State Univ. (Armenia)
Aram G. Gyulkhandanyan, Yerevan State Univ. (Armenia)
Gennadi H. Gasparyan, Institute of Zoology of Armenian NAS (Armenia)


Published in SPIE Proceedings Vol. 5689:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XIV
David Kessel, Editor(s)

© SPIE. Terms of Use
Back to Top